MedPath

One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery

Not Applicable
Conditions
Coronary Artery Bypass
Interventions
Device: EZ-Blocker
Registration Number
NCT02823054
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Coronary artery bypass grafting is a current cardiac surgery. Internal thoracic artery is usually taking to restore coronary revascularization, and its dissection can lead to accidental or voluntary pleural effusions. Respiratory complications are frequent, due to the drainage required. In this study, the investigators propose one-lung ventilation to facilitate artery grafting and surgical procedure. The investigators will include all adult patients with elective coronary artery bypass surgery (CABG) by internal thoracic artery, in a prospective, controlled, randomized and monocentric study. The main objective is to demonstrate that one-lung ventilation using EZ-Blocker can reduce pleural effusion defined by presence of drainage and/or pneumothorax on X-ray chest in the ICU.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
208
Inclusion Criteria
  • elective CABG surgery with internal thoracic artery, with patient consent.
  • Patient who have french social security
Exclusion Criteria
  • Cardiac or thoracic past-history
  • polyurethane allergy
  • guardianship patient
  • endotracheal intern diameter too small to allow the EZ-Blocker introduction or the fiberscope
  • use of LASER immediately near the EZ-Blocker

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EZ-Blocker groupEZ-Blockerone lung ventilation 'EZ-Blocker'
Primary Outcome Measures
NameTimeMethod
Pleural effusions after coronary artery bypass graft surgeryDay 0

quantifying the number of thoracic drains (0, 1 or 2), as accidental or voluntary pleural effusion

absence of pneumothoraxDay 0

verify the absence of pneumothorax to X-ray chest ( not drained pleural effusion).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath